Rehabtronics Receives $1.25 Million from Genome BC
Rehabtronics notes the funds will facilitate free 90-day quality improvement trials of Prelivia at qualified healthcare facilities in the United States.
March 15, 2022
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Scinvivo Secures 1 Mil Investment for In Human Clinical Trials & CE
Marijn van Os, CEO of Scinvivo: “With this investment, we will make the first steps in the clinics and show the incredibly high-resolution tissue images captured with our platform.”
March 11, 2022
OSF Ventures Joins Early Financing for 1st FDA-cleared Wireless Seizure Detection Sensor
Catalyst Health Ventures (CHV) and Genoa Ventures co-led the over-subscribed early financing along with participation from Dexcom, Inc. (DXCM), Wavemaker 360, and existing investors MedMountain Ventures and Salt Lake City Angels.
March 10, 2022
